Andrew Davison

Andrew Davison is currently the Chief Quality Officer at Sterile since February 2024. Prior to this role, Andrew held various positions in quality management and regulatory affairs at Genesys Spine, Apollo Endosurgery, and Inova Labs. With his extensive experience in maintaining regulatory compliance with FDA regulations and international quality standards, Andrew has demonstrated leadership in managing quality systems, supplier audits, CAPA programs, and process validation activities. He has a solid track record of developing and implementing quality plans, procedures, and audits to ensure excellence in product quality and regulatory compliance. Andrew's expertise in quality management spans across different industries, making him a valuable asset in ensuring quality and compliance within organizations.